Washington Center for Bleeding Disorders

Running trials

• Recruiting

  A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

  NCT07416604· Phase 3· Source

• Recruiting

  Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A

  NCT05500807· Phase 1· Source

• Active, not recruiting

  Emicizumab in Patients With Acquired Hemophilia A

  NCT05345197· Phase 2· Source

• Recruiting

  ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

  NCT04398628· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Haemophilia3 recruiting
• Sickle cell disease1 recruiting
• Thalassaemia1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Terminated

  BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

  NCT06611436· Phase 1/2· Source